Gyre Therapeutics Inc (GYRE)

Net Change in Cash

$5.79M

Quarterly · Period ending: · USD

GYRE logo

GYRE Net Change in Cash

Latest reported$5.79M
GYRE Quarterly Net Change in Cash (-$7.34M → $5.79M)
High-resolution chart · PNG

GYRE net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
5,786,000
431,000
-3,332,000
3,911,000
21,446,000
3,232,000
-4,053,000
-231,000
-13,688,000
-3,724,000
7,430,000
2,353,000
-4,418,000
-13,567,000
2,085,000
-52,304,000
40,577,000
5,745,316
-14,810,000
-14,464,000
-9,423,000
52,684,000
5,437,000
-34,350,000
-11,091,000
54,995,000
-7,649,000
5,620,000
-7,676,000
-6,189,000
-4,785,000
-10,660,000
-80,017,000
106,920,000
3,499,000
-21,415,000
17,855,000
4,269,000
947,000
-2,016,000
-9,247,000
-8,516,000
6,000,000
-55,102,000
5,085,000
16,683,000
10,723,000
2,290,000
-1,624,000
-9,444,000
-7,254,000
-1,320,000
-6,802,000
-12,379,000
4,038,000
6,557,000
-17,023,000
-18,615,000
-23,258,000
-37,601,000
29,305,000
-27,017,000
-19,945,000
-35,827,000
-20,324,000
158,041,000
35,680,000
2,310,000
2,914,000
-8,197,000
-10,299,842
-2,863,802
-1,100,964
12,063,516
1,531,641
9,286,119
-12,594,643
13,435,612
-4,769,568
-4,863,520
24,177,308
2,348,841
-5,888,725
-8,383,892
-6,607,678
-7,343,751
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.